Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482 · see citing works

Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children

Kearns, G. L., Abdel‐Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,420 · see citing works

Bone grafts and biomaterials substitutes for bone defect repair: A review

Wang, W., & Yeung, K. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.05.007 · Cited by 1,972 · see citing works

Attention-deficit/hyperactivity disorder

Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479 · see citing works

Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders

Nelson, S. B., & Valakh, V. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.033 · Cited by 1,001 · see citing works

Pompe's disease

van der Ploeg, A. T., & Reuser, A. J. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61555-x · Cited by 758 · see citing works

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.02.010 · Cited by 728 · see citing works

Epileptogenesis in the immature brain: emerging mechanisms

Rakhade, S. N., & Jensen, F. E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.80 · Cited by 554 · see citing works

Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth

Lacroix, D. A., Sonnier, M., Moncion, A., Chéron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 537 · see citing works

Development of the Hemostatic System in the Neonate and Young Infant

Andrew, M. E., Paes, B. A., & Johnston, M. (1990) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199021000-00019 · Cited by 532 · see citing works

Human renal function maturation: a quantitative description using weight and postmenstrual age

Rhodin, M. M., Anderson, B. J., Peters, A. M., et al. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0997-5 · Cited by 499 · see citing works

Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force

Matza, L. S., Patrick, D. L., Riley, A. W., Alexander, J. J., Rajmil, L., Pleil, A. M., & Bullinger, M. (2013) · Value in Health · doi:10.1016/j.jval.2013.04.004 · Cited by 478 · see citing works

Developmental Changes in Pharmacokinetics and Pharmacodynamics

van den Anker, J. N., Reed, M. D., Allegaert, K., & Kearns, G. L. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1284 · Cited by 391 · see citing works

Sampling interstitial fluid from human skin using a microneedle patch

Samant, P. P., Niedzwiecki, M. M., Raviele, N., Tran, V., Mena-Lapaix, J. L., Walker, D. I., Felner, E. I., Jones, D. P., Miller, G. W., & Prausnitz, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0285 · Cited by 387 · see citing works

Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010

Chai, G. P., Governale, L. A., McMahon, A. W., Trinidad, J. P., Staffa, J. A., & Murphy, D. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2879 · Cited by 370 · see citing works

Liver organoids: from basic research to therapeutic applications

Prior, N., Inacio, P., & Huch, M. (2019) · Gut · doi:10.1136/gutjnl-2019-319256 · Cited by 356 · see citing works

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

Wirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A.-L., & Heller, R. (2006) · Human Genetics · doi:10.1007/s00439-006-0156-7 · Cited by 355 · see citing works

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336 · see citing works

The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper

Adeli, K., Higgins, V., Trajcevski, K. E., & Habeeb, N. W.-A. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1379945 · Cited by 310 · see citing works

Ontogeny of human hepatic cytochromes P450

Hines, R. N. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20179 · Cited by 276 · see citing works

Improving Bioscience Research Reporting: The <scp>ARRIVE</scp> Guidelines for Reporting Animal Research

(2012) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2012.00418.x · Cited by 269 · see citing works

Intrauterine growth restriction – part 1

Sharma, D. K., Shastri, S., Farahbakhsh, N., & Sharma, P. K. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1152249 · Cited by 249 · see citing works

Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva

Patsalos, P. N., & Berry, D. J. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31827c11e7 · Cited by 190 · see citing works

A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group

Luyckx, V. A., Perico, N., Somaschini, M., Manfellotto, D., Valensise, H. C. C., Cetin, I., Siméoni, U., Allegaert, K., Vikse, B. E., Steegers, E. A. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30576-7 · Cited by 181 · see citing works

Trends in Prescription Medication Use Among Children and Adolescents—United States, 1999-2014

Hales, C. M., Kit, B. K., Gu, Q., & Ogden, C. L. (2018) · JAMA · doi:10.1001/jama.2018.5690 · Cited by 176 · see citing works

A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)

on behalf of the IICARus Collaboration, Hair, K., Macleod, M. R., & Sena, E. S. (2019) · Research Integrity and Peer Review · doi:10.1186/s41073-019-0069-3 · Cited by 174 · see citing works

Tips and traps analyzing pediatric PK data

Anderson, B. J., & Holford, N. H. G. (2011) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2011.03536.x · Cited by 163 · see citing works

Intrauterine growth restriction – part 2

Sharma, D. K., Farahbakhsh, N., Shastri, S., & Sharma, P. K. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1154525 · Cited by 157 · see citing works

Ontogeny of Human Hepatic and Intestinal Transporter Gene Expression during Childhood: Age Matters

Mooij, M. G., Schwarz, U. I., de Koning, B. A. E., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.056929 · Cited by 156 · see citing works

Quantifying the development of the peripheral naive CD4+ T-cell pool in humans

Bains, I., Antia, R., Callard, R. E., & Yates, A. J. (2009) · Blood · doi:10.1182/blood-2008-10-184184 · Cited by 153 · see citing works

Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population

Duarah, S., Sharma, M., & Wen, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.005 · Cited by 152 · see citing works

LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE

Fakhoury, M., Litalien, C., Médard, Y., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005611 · Cited by 150 · see citing works

WATER DISTRIBUTION IN THE FOETUS AND NEWBORN INFANT

Friis-Hansen, B. (1983) · Acta Paediatrica · doi:10.1111/j.1651-2227.1983.tb09852.x · Cited by 149 · see citing works

Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

Schrier, L., Hadjipanayis, A., Stiris, T., Ross-Russell, R. I., Valiulis, A., Turner, M. A., Zhao, W., Cock, P. A. J. G. D., de Wildt, S. N., Allegaert, K., et al. (2020) · European Journal of Pediatrics · doi:10.1007/s00431-019-03556-9 · Cited by 146 · see citing works

Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes

Norman, J. J., Brown, M. R., Raviele, N., Prausnitz, M. R., & Felner, E. I. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12031 · Cited by 142 · see citing works

Quantifying Thymic Export: Combining Models of Naive T Cell Proliferation and TCR Excision Circle Dynamics Gives an Explicit Measure of Thymic Output

Bains, I., Thiébaut, R., Yates, A. J., & Callard, R. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900743 · Cited by 131 · see citing works

A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

Salem, F., Johnson, T. N., Abduljalil, K., Tucker, G. T., & Rostami‐Hodjegan, A. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0140-7 · Cited by 129 · see citing works

Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids

Vonk, A. M., van Mourik, P., Ramalho, A. S., Silva, I. A. L., Statia, M., Kruisselbrink, E., Suen, S. W. F., Dekkers, J. F., Vleggaar, F. P., Houwen, R. H. J., et al. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100019 · Cited by 128 · see citing works

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells

Shoji, E., Sakurai, H., Nishino, T., Nakahata, T., Heike, T., Awaya, T., FUJII, N. L., Manabe, Y., Matsuo, M., & Sehara‐Fujisawa, A. (2015) · Scientific Reports · doi:10.1038/srep12831 · Cited by 126 · see citing works

Age‐ and Genotype‐Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate‐Glucuronosyltransferases in Human Liver

Bhatt, D. K., Mehrotra, A., Gaedigk, A., Chapa, R., Basit, A., Zhang, H., Choudhari, P., Boberg, M., Pearce, R. E., Gaedigk, R., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1109 · Cited by 124 · see citing works

Proposals for model‐based paediatric medicinal development within the current European Union regulatory framework

Manolis, E., & Pons, G. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03484.x · Cited by 122 · see citing works

Adolescent nicotine induces persisting changes in development of neural connectivity.

Smith, R. F., McDonald, C. G., Bergstrom, H. C., Ehlinger, D. G., & Brielmaier, J. M. (2015) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.019 · Cited by 120 · cited 1× · see citing works

Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007

Momper, J. D., Mulugeta, Y. A., Green, D. J., Karesh, A., Krudys, K. M., Sachs, H. C., Yao, L. P., & Burckart, G. J. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.465 · Cited by 114 · see citing works

Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species

van Groen, B. D., Nicolaï, J., Kuik, A. C., Cruchten, S. J. M. V., Peer, E. M. V., Smits, A., Schmidt, S., de Wildt, S. N., Allegaert, K., Schaepdrijver, L. D., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000071 · Cited by 112 · see citing works

Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups

Huang, N. Ν., & High, R. H. (1953) · The Journal of Pediatrics · doi:10.1016/s0022-3476(53)80422-1 · Cited by 109 · see citing works

A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization

Cheung, K. W. K., van Groen, B. D., Spaans, E., van Borselen, M. D., de Bruijn, A. C. J. M., Simons-Oosterhuis, Y., Tibboel, D., Samsom, J. N., Verdijk, R. M., Smeets, B., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1516 · Cited by 108 · see citing works

Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children

Vet, N. J., Brussee, J. M., de Hoog, M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2114oc · Cited by 106 · see citing works

Renal Drug Clearance in Preterm Neonates: Relation to Prenatal Growth

Allegaert, K., Anderson, B. J., van den Anker, J. N., Vanhaesebrouck, S., & de Zegher, F. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31806db3f5 · Cited by 105 · see citing works

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Conklin, L. S., Damsker, J. M., Hoffman, E. P., Jusko, W. J., Mavroudis, P. D., Schwartz, B. D., Mengle-Gaw, L. J., Smith, E. C., Mah, J. K., Guglieri, M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.007 · Cited by 103 · see citing works

Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs

Yoshida, M., Kitaoka, S., Egawa, N., Yamane, M., Ikeda, R., Tsukita, K., Amano, N., Watanabe, A., Morimoto, M., Takahashi, J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.010 · Cited by 102 · see citing works

Ontogeny of human pancreatic exocrine function.

McClean, P., & Weaver, L. T. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.1_spec_no.62 · Cited by 102 · see citing works

Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients

Gijsen, V. M. G. J., Mital, S. R., van Schaik, R. H., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.08.001 · Cited by 102 · see citing works

Paracetamol and metabolite pharmacokinetics in infants

van der Marel, C. D., Anderson, B. J., van Lingen, R. A., Holford, N. H. G., Pluim, M. A. L., Jansman, F. G. A., van den Anker, J. N., & Tibboel, D. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0608-0 · Cited by 98 · see citing works

Hormonal Regulation of Hepatic Drug-Metabolizing Enzyme Activity During Adolescence

Kennedy, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.202 · Cited by 96 · see citing works

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Hoffman, E. P., Schwartz, B. D., Mengle-Gaw, L. J., Smith, E. C., Castro, D., Mah, J. K., McDonald, C. M., Kuntz, N. L., Finkel, R. S., Guglieri, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008168 · Cited by 96 · see citing works

Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions

Nicolas, J., Bouzom, F., Chanteux, H., et al. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2052 · Cited by 96 · see citing works

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs

van den Anker, J. N., McCune, S., Annaert, P., Baer, G., Mulugeta, Y. A., Abdelrahman, R. A., Wu, K., Krudys, K. M., Fisher, J. W., Slikker, W., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070685 · Cited by 95 · see citing works

Impact of asymmetric intrauterine growth restriction on organ function in newborn piglets

Bauer, R., Walter, B. L., Brust, P., Füchtner, F., & Zwiener, U. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00171-4 · Cited by 92 · see citing works

Simultaneous Pharmacokinetic Modeling of Gentamicin, Tobramycin and Vancomycin Clearance from Neonates to Adults: Towards a Semi-physiological Function for Maturation in Glomerular Filtration

Cock, R. F. W. D., Allegaert, K., Brussee, J. M., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1361-z · Cited by 91 · see citing works

Dosing dilemmas in obese children

Mulla, H., & Johnson, T. N. (2010) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2009.163055 · Cited by 89 · see citing works

Effect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants

Blake, M. J., Abdel‐Rahman, S. M., Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000245909.74166.00 · Cited by 87 · see citing works

Ontogeny of oral drug absorption processes in children

Mooij, M. G., de Koning, B. A., Huijsman, M. L., et al. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.698261 · Cited by 87 · see citing works

Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children

Study, H. P. P. M. C. (2006) · AIDS · doi:10.1097/01.aids.0000232237.20792.68 · Cited by 86 · see citing works

Role of modeling and simulation in pediatric investigation plans

Manolis, E., Osman, T. E., Herold, R., König, F., Tomasi, P. A., Vamvakas, S., & Saint-Raymond, A. (2011) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2011.03523.x · Cited by 84 · see citing works

Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity

Aleksa, K., Matsell, D. G., Krausz, K., Gelboin, H. V., Ito, S., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1807-3 · Cited by 82 · see citing works

Skeletal maturation and growth rates are related to bone and growth plate injuries in adolescent athletics

Wik, E. H., Martínez‐Silván, D., Farooq, A., et al. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13635 · Cited by 82 · see citing works

Age‐related reference ranges: Significance tests for models and confidence intervals for centiles

Wade, A. M., & Ades, A. E. (1994) · Statistics in Medicine · doi:10.1002/sim.4780132207 · Cited by 80 · see citing works

Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

Leroux, S., Turner, M. A., Guellec, C. B., et al. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0291-1 · Cited by 79 · see citing works

Involving children and young people in clinical research through the forum of a European Young Persons’ Advisory Group: needs and challenges

Gaillard, S., Malik, S., Preston, J., et al. (2018) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12360 · Cited by 78 · see citing works

Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin

Sethi, P. K., White, C. A., Cummings, B. S., et al. (2015) · Pediatric Research · doi:10.1038/pr.2015.237 · Cited by 77 · see citing works

Plasma 4β-Hydroxycholesterol: An Endogenous CYP3A Metric?

Tomalik‐Scharte, D., Lütjohann, D., Doroshyenko, O., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.72 · Cited by 75 · see citing works

Developmental Pharmacokinetics of Piperacillin and Tazobactam Using Plasma and Dried Blood Spots from Infants

Cohen‐Wolkowiez, M., Watt, K., Zhou, C., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02139-13 · Cited by 75 · see citing works

Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma

Frommelt, P. C., Juern, A. M., Siegel, D. H., et al. (2016) · Pediatric Dermatology · doi:10.1111/pde.12869 · Cited by 75 · see citing works

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Germovsek, E., Lutsar, I., Kipper, K., Karlsson, M. O., Planche, T., Chazallon, C., Meyer, L., Trafojer, U., Metsvaht, T., Fournier, I., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky128 · Cited by 75 · see citing works

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics

Mooij, M. G., Nies, A. T., Knibbe, C. A. J., Schaeffeler, E., Tibboel, D., Schwab, M. G., & de Wildt, S. N. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0328-5 · Cited by 72 · see citing works

Development of a neonatal adverse event severity scale through a Delphi consensus approach

Salaets, T., Turner, M. A., Short, M., et al. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-317399 · Cited by 71 · see citing works

Developmental pharmacodynamics of cyclosporine

MARSHALL, J., & KEARNS, G. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70055-x · Cited by 69 · see citing works

Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs

Engelhart, D. C., Granados, J. C., Shi, D., Saier, M. H., Baker, M. E., Abagyan, R. A., & Nigám, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051791 · Cited by 69 · see citing works

Advances in detection of antipsychotics in biological matrices

Patteet, L., Cappelle, D., Maudens, K. E. K., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.008 · Cited by 64 · see citing works

Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism

Ladumor, M. K., Bhatt, D. K., Gaedigk, A., Sharma, S., Thakur, A., Pearce, R. E., Leeder, J. S., Bolger, M. B., Singh, S., & Prasad, B. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086462 · Cited by 64 · see citing works

Composition of the fat-free mass in obese and nonobese children: matched case–control analyses

Haroun, D., Wells, J. C. K., Williams, J. E., Fuller, N. J., Fewtrell, M. S., & Lawson, M. S. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802834 · Cited by 63 · see citing works

Translational Advances in Pediatric Nutrition and Gastroenterology: New Insights from Pig Models

Burrin, D. G., Sangild, P. T., Stoll, B., Thymann, T., Buddington, R. K., Marini, J. C., Olutoye, O. O., & Shulman, R. J. (2020) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115142 · Cited by 63 · see citing works

Challenges in clinical trials for children and young people

Lagler, F. B., Hirschfeld, S., & Kindblom, J. M. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318676 · Cited by 61 · see citing works

Changes in body composition during refeeding of patients with anorexia nervosa

Vaisman, N., Corey, M. L., Rossi, M., Goldberg, E., & Pencharz, P. B. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80033-7 · Cited by 60 · see citing works

A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials

Gaasterland, C. M. W., der Weide, M. C. J., Weinreich, S. S., & van der Lee, J. H. (2016) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0205-4 · Cited by 59 · see citing works

Erratum: Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders

Lemonnier, É., Villeneuve, N., Sonié, S., Serret, S., Rosier, A., Roue, M., Brosset, P., Viellard, M., Bernoux, D., Rondeau, S., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.101 · Cited by 59 · see citing works

The Influence of Age and Sex on the Electrocardiogram

Macfarlane, P. W. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_6 · Cited by 59 · see citing works

Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A

Mao, J., Martin, I. J., McLeod, J. F., et al. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1239630 · Cited by 59 · see citing works

Stabilizing Drug Molecules in Biological Samples

Chen, J., & Hsieh, Y. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000170879.18139.40 · Cited by 58 · see citing works

Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry: Method validation and application to a neonatal pharmacokinetic study

Cook, S. F., King, A. D., van den Anker, J. N., et al. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.10.013 · Cited by 57 · see citing works

Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions

Allegaert, K., Smits, A., van Donge, T., van den Anker, J. N., Sarafidis, K., Levtchenko, E. N., & Mekahli, D. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00366 · Cited by 56 · see citing works

Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling

Bi, Y., Liu, J., Li, L., Yu, J., Bhattaram, A., Bewernitz, M., Li, R., Liu, C., Earp, J. C., Ma, L., et al. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1478 · Cited by 54 · see citing works

Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge

Raffaeli, G., Pokorná, P., Allegaert, K., Mosca, F., Cavallaro, G., Wildschut, E. D., & Tibboel, D. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00360 · Cited by 54 · see citing works

Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model

Cook, S. F., Stockmann, C. R., Samiee‐Zafarghandy, S., et al. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0408-1 · Cited by 53 · see citing works

How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology Approach

Johnson, T. N., Jamei, M., & Rowland‐Yeo, K. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068643 · Cited by 53 · see citing works

A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration

Liu, X. I., Schuette, P., Burckart, G. J., Green, D. J., La, J., Burnham, J. M., Rakhmanina, N. Y., Robb, A. S., Huang, S. M., & van den Anker, J. N. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.12.033 · Cited by 52 · see citing works

The interplay between drugs and the kidney in premature neonates

Schreuder, M. F., Bueters, R., & Allegaert, K. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2651-0 · Cited by 50 · see citing works

Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations

Oyaert, M., Spriet, I., Allegaert, K., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01185-15 · Cited by 50 · see citing works

Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters

Cheung, K. W. K., van Groen, B. D., Burckart, G. J., Zhang, L., de Wildt, S. N., & Huang, S. M. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1489 · Cited by 48 · see citing works

A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates

Smits, A., Annaert, P., Cruchten, S. J. M. V., & Allegaert, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00587 · Cited by 48 · see citing works

A Swine Model of Neonatal Asphyxia

Cheung, P., Gill, R. S., & Bigam, D. L. (2011) · Journal of Visualized Experiments · doi:10.3791/3166 · Cited by 48 · see citing works

Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology

Allegaert, K., Simons, S. H. P., Tibboel, D., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.023 · Cited by 47 · see citing works

Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants

Flint, R. B., Roofthooft, D. W. E., van Rongen, A., et al. (2017) · Pediatric Research · doi:10.1038/pr.2017.129 · Cited by 47 · see citing works

Evidence-based drug treatment for special patient populations through model-based approaches

Krekels, E. H. J., van Hasselt, J. G. C., van den Anker, J. N., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.022 · Cited by 45 · see citing works

Time course of the increase in 4β‐hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy

Wide, K., Larsson, H., Bertilsson, L., et al. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03078.x · Cited by 45 · see citing works

Paediatric extrapolation: A necessary paradigm shift

Ollivier, C., Mulugeta, Y. A., Ruggieri, L., Saint-Raymond, A., & Yao, L. P. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13809 · Cited by 44 · see citing works

Gastric fluid composition in a paediatric population: Age-dependent changes relevant for gastrointestinal drug disposition

Αbeele, J. V. D., Rayyan, M., Hoffman, I. E. A., et al. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.022 · Cited by 43 · see citing works

Developmental patterns in human blood–brain barrier and blood–cerebrospinal fluid barrier ABC drug transporter expression

Verscheijden, L. F. M., van Hattem, A. C., Pertijs, J. C. L. M., de Jongh, C. A., Verdijk, R. M., Smeets, B., Koenderink, J. B., Rüssel, F. G. M., & de Wildt, S. N. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01884-8 · Cited by 43 · see citing works

The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development

Ayuso, M., Buyssens, L. A., Stroe, M., Valenzuela, A., Allegaert, K., Smits, A., Annaert, P., Mulder, A., Carpentier, S., Ginneken, C. J. V., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010044 · Cited by 43 · see citing works

Ontogeny of Phase I Metabolism of Drugs

Allegaert, K., & van den Anker, J. N. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1483 · Cited by 42 · see citing works

Commentary on the EMA R eflection P aper on the use of extrapolation in the development of medicines for paediatrics

Ollivier, C., Thomson, A., Manolis, E., Blake, K. V., Karlsson, K. E., Knibbe, C. A. J., Pons, G., & Hemmings, R. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13883 · Cited by 42 · see citing works

Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review

Lutz, I. C., Allegaert, K., Hoon, J. N. J. M. D., & Marynissen, H. (2020) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2020-000685 · Cited by 41 · see citing works

Drug Studies in Newborns: A Therapeutic Imperative

Giacoia, G. P., Taylor‐Zapata, P., & Zajicek, A. (2012) · Clinics in Perinatology · doi:10.1016/j.clp.2011.12.016 · Cited by 40 · see citing works

Does “Birth” as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full‐Term Neonates by Avoiding the Creatinine Bias

Salem, F., Johnson, T. N., Hodgkinson, A., Ogungbenro, K., & Rostami‐Hodjegan, A. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1725 · Cited by 40 · see citing works

Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute

Smits, A., Cock, P. A. J. G. D., Vermeulen, A., et al. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1558205 · Cited by 38 · see citing works

Ontogeny and Cross-species Comparison of Pathways Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Neonates (Review): Kidney

Bueters, R., Bael, A., Gasthuys, E., Chen, C. L., Schreuder, M. F., & Frazier, K. S. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089755 · Cited by 38 · see citing works

Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants

Krekels, E. H. J., van Ham, S., Allegaert, K., et al. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1887-y · Cited by 35 · see citing works

Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development

Chen, S., Li, P., Wang, Y., Yin, Y., de Ruiter, P. E., Verstegen, M. M. A., Peppelenbosch, M. P., van der Laan, L. J. W., & Pan, Q. (2020) · mBio · doi:10.1128/mbio.01968-20 · Cited by 34 · see citing works

Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens

Stockmann, C. R., Barrett, J. S., Roberts, J., & Sherwin, C. M. T. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12038 · Cited by 34 · see citing works

A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans

Kiang, T. K. L., & Ensom, M. H. H. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0321-z · Cited by 33 · see citing works

Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept

Mooij, M. G., van Duijn, E., Knibbe, C. A. J., et al. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0176-8 · Cited by 33 · see citing works

To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics

Bosgra, S., Vlaming, M. L. H., & Vaes, W. H. J. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0308-9 · Cited by 33 · see citing works

The pharmacology of anaesthetics in the neonate

Anderson, B. J., & Allegaert, K. (2010) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2010.02.019 · Cited by 32 · see citing works

Topical and oral minoxidil for hair disorders in pediatric patients: What do we know so far?

Lemes, L. R., Melo, D. F., de Oliveira, D. S., et al. (2020) · Dermatologic Therapy · doi:10.1111/dth.13950 · Cited by 32 · see citing works

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study

van Groen, B. D., Krekels, E. H. J., Mooij, M. G., van Duijn, E., Vaes, W. H. J., Windhorst, A. D., van Rosmalen, J., Hartman, S. J. F., Hendrikse, N. H., Koch, B. C. P., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1890 · Cited by 31 · see citing works

Barriers to Drug Distribution into the Perinatal and Postnatal Brain

Ghersi‐Egea, J., Saudrais, É., & Strazielle, N. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2375-8 · Cited by 30 · see citing works

Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study

Langhof, H., Chin, W. W. L., Wieschowski, S., Federico, C. A., Kimmelman, J., & Strech, D. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14485 · Cited by 29 · see citing works

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)

Willmann, R., Lee, J., Turner, C., Nagaraju, K., Aartsma-Rus, A. M., Wells, D. J., Wagner, K. R., Csimma, C., Straub, V. W., Grounds, M. D., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042903 · Cited by 28 · see citing works

A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots

Bona, M. L. D., Malvagia, S., Villanelli, F., et al. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.01.034 · Cited by 28 · see citing works

Quantitative retrospective natural history modeling for orphan drug development

Garbade, S. F., Zielonka, M., Komatsuzaki, S., Kölker, S., Hoffmann, G. F., Hinderhofer, K., Mountford, W. K., Mengel, E., Sláma, T., Mechler, K., et al. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12304 · Cited by 27 · see citing works

Developmental Pharmacodynamics and Modeling in Pediatric Drug Development

Conklin, L. S., Hoffman, E. P., & van den Anker, J. N. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1482 · Cited by 27 · see citing works

Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children’s Pediatric Innovation Research Forum

Noel, G. J., Nelson, R. M., Bucci-Rechtweg, C. M., Portman, R. J., Miller, T., Green, D. J., Snyder, D. L., Moreno, C., Hovinga, C. A., & Connor, E. M. (2021) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-021-00283-y · Cited by 26 · see citing works

Protein Binding of Flucloxacillin in Neonates

Pullen, J., Stolk, L. M., Degraeuwe, P. L. J., et al. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318063e30f · Cited by 26 · see citing works

Neonatal Phenobarbital and Phenytoin Binding Profiles

Painter, M. J., Minnigh, M. B., GAUS, L. M., et al. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb01999.x · Cited by 25 · see citing works

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps

Kelly, L. E., Sinha, Y., Barker, C. I. S., Standing, J. F., & Offringa, M. (2018) · Pediatric Research · doi:10.1038/pr.2018.38 · Cited by 25 · see citing works

Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants

Vauzelle-Kervroedan, F., Rey, E., Pariente‐Khayat, A., et al. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050162 · Cited by 24 · see citing works

Prospective identification and causality evaluation of suspected adverse drug reactions in neonates

Roberts, E., Hawcutt, D. B., & Turner, M. A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14485 · Cited by 24 · see citing works

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates

Leroux, S., van den Anker, J. N., Smits, A., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13899 · Cited by 24 · see citing works

Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism

Mooij, M. G., van Duijn, E., Knibbe, C. A. J., et al. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0508-6 · Cited by 23 · see citing works

Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period

Soo, J. Y., Wiese, M. D., Berry, M. J., McMillen, I. C., & Morrison, J. L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.003 · Cited by 23 · see citing works

Assessment of Autism Zebrafish Mutant Models Using a High-Throughput Larval Phenotyping Platform

Colón-Rodríguez, A., Uribe‐Salazar, J. M., Weyenberg, K., Sriram, A., Quezada, A., Kaya, G., Jao, E., Radke, B., Lein, P. J., & Dennis, M. Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.586296 · Cited by 23 · see citing works

The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study

Cristea, S., Krekels, E. H. J., Rostami‐Hodjegan, A., et al. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00468-7 · Cited by 22 · see citing works

Pharmacokinetics in children with chronic kidney disease

Schijvens, A. M., de Wildt, S. N., & Schreuder, M. F. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04304-9 · Cited by 22 · see citing works

Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol

Nylén, H., Sergel, S., Forsberg, L., et al. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0984-1 · Cited by 22 · see citing works

Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition

Standing, J. F., Ongas, M. O., Ogwang, C., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1078 · Cited by 22 · see citing works

Dose-Related Concentrations of Neuroactive/Psychoactive Drugs Expected in Blood of Children and Adolescents

Fekete, S., Hiemke, C., & Gerlach, M. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000685 · Cited by 22 · see citing works

Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents

van Donge, T., Staub, E., Atkinson, A., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0781 · Cited by 22 · see citing works

Predicting CD4 T‐Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation

Hoare, R. L., Veys, P. A., Klein, N. J., Callard, R. E., & Standing, J. F. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.621 · Cited by 21 · see citing works

Observational infant exploratory [14C]‐paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis

Garner, C. R., Park, K. B., French, N. S., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12597 · Cited by 21 · see citing works

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials

Davis, J. M., Baer, G., McCune, S., et al. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.09.060 · Cited by 21 · see citing works

Hepatic Cytochrome P450 Abundance and Activity in the Developing and Adult Göttingen Minipig: Pivotal Data for PBPK Modeling

Buyssens, L. A., Clerck, L. D., Schelstraete, W., Dhaenens, M., Deforce, D. L. D., Ayuso, M., Ginneken, C. J. V., & Cruchten, S. J. M. V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.665644 · Cited by 21 · see citing works

Pharmacokinetic analysis of 14C‐ursodiol in newborn infants using accelerator mass spectrometry

Gordi, T., Baillie, R., Vuong, L. T., et al. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.327 · Cited by 20 · see citing works

Nephrotic syndrome in a dish: recent developments in modeling in vitro

Veissi, S. T., Smeets, B., van den Heuvel, L. P., Schreuder, M. F., & Jansen, J. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-4203-8 · Cited by 20 · see citing works

Changes in urinary 6β-hydroxycortisol/cortisol ratio after birth in human neonates

Nakamura, H., HIRAI, M., Ohmori, S., et al. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050390 · Cited by 20 · see citing works

Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus

Engbers, A. G. J., Flint, R. B., Völler, S., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14298 · Cited by 20 · see citing works

Research in human resuscitation: what we learn from animals

Barouxis, D., Chalkias, A. F., Syggelou, A., et al. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.714633 · Cited by 20 · see citing works

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns

Flint, R. B., ter Heine, R., Spaans, E., et al. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2529-y · Cited by 19 · see citing works

Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study

Linakis, M. W., Cook, S. F., Kumar, S. S., et al. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0634-9 · Cited by 19 · see citing works

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

Zhao, W., Leroux, S., Biran, V., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13526 · Cited by 19 · see citing works

Sedative and Analgesic Pharmacokinetics During Pediatric ECMO

Zimmerman, K. O., Dallefeld, S. H., Hornik, C. P. V., et al. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.8.675 · Cited by 19 · see citing works

Best Practices and Standard Protocols as a Tool to Enhance Translation for Neuromuscular Disorders

Willmann, R., Luca, A. D., Nagaraju, K., & Rüegg, M. A. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140067 · Cited by 19 · see citing works

Cefazolin plasma protein binding in different human populations: More than cefazolin–albumin interaction

Smits, A., Roberts, J. A., Vella-Brincat, J., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.008 · Cited by 18 · see citing works

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view

Boeck, K. D., Lee, T., Amaral, M. D., Dřevı́nek, P., Elborn, J. S., Fajac, I., Kerem, E., & Davies, J. C. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.05.012 · Cited by 18 · see citing works

Fallback tests for co‐primary endpoints

Ristl, R., Frommlet, F., Koch, A., & Posch, M. (2016) · Statistics in Medicine · doi:10.1002/sim.6911 · Cited by 17 · see citing works

Vancomycin Elimination in Human Infants With Intrauterine Growth Retardation

Frattarelli, D. A. C., Ergün, H., Lulic-Botica, M., Lehr, V. T., & Aranda, J. V. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000186283.95728.34 · Cited by 17 · see citing works

Practical Challenges—Use of Paracetamol in Children and Youth Who are Overweight or Obese: A Narrative Review

Zempsky, W. T., Bhagat, P. K., & Siddiqui, K. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00417-z · Cited by 15 · see citing works

Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials

Kearns, G. L., & Artman, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150901105337 · Cited by 15 · see citing works

Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease

Spineli, L. M., Jenz, E., Großhennig, A., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0692-3 · Cited by 15 · see citing works

A 300 μm Organotypic Bone Slice Culture Model for Temporal Investigation of Endochondral Osteogenesis

Srinivasaiah, S., Musumeci, G., Mohan, T., Castrogiovanni, P., Absenger‐Novak, M., Zefferer, U., Mostofi, S., Rad, E. B., Grün, N. G., Weinberg, A., et al. (2019) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0368 · Cited by 15 · see citing works

Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible

DʼAgate, S., Musuamba, F. T., & Pasqua, O. E. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.521933 · Cited by 15 · see citing works

Impact of small‐for‐gestational age (SGA) status on gentamicin pharmacokinetics in neonates

Lulic‐Botica, M., Sheer, T., Edwards, D. J., et al. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.190 · Cited by 14 · see citing works

Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

Standing, J. F., Anderson, B. J., Holford, N. H. G., et al. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0344-5 · Cited by 14 · see citing works

Organ data from the developing Göttingen minipig: first steps towards a juvenile PBPK model

Peer, E. V., Downes, N., Casteleyn, C. R., et al. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9463-8 · Cited by 14 · see citing works

Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7–18 Years

Zhang, H., Basit, A., Wolford, C., Chen, K., Gaedigk, A., Lin, Y. S., Leeder, J. S., & Prasad, B. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1764 · Cited by 13 · see citing works

New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges

Ricci, F., Vacchetti, M., Brusa, C., Vercelli, L., Davico, C., Vitiello, B., & Mongini, T. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1634543 · Cited by 13 · see citing works

Simvastatin attenuates lung functional and vascular effects of hyperoxia in preterm rabbits

Salaets, T., Tack, B., Jiménez, J., Gie, A. G., Lesage, F., de Winter, D. P., Berghen, N., Allegaert, K., Deprest, J. A., & Toelen, J. (2019) · Pediatric Research · doi:10.1038/s41390-019-0711-2 · Cited by 12 · see citing works

Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials

Sridharan, K., Hasan, H., Jufairi, M. A., et al. (2021) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2021.103628 · Cited by 12 · see citing works

Towards Modelling Genetic Kidney Diseases with Human Pluripotent Stem Cells

Rooney, K. M., Woolf, A. S., & Kimber, S. J. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514018 · Cited by 11 · see citing works

An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children: Age-dependent protein binding

Kan, M., Wu, Y., Li, X., et al. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122081 · Cited by 10 · see citing works

Urinary and serum oxysterols in children: developmental pattern and potential biomarker for pediatric liver disease

Takaki, Y., Mizuochi, T., Takei, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63758-2 · Cited by 10 · see citing works

Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients

Lochmüller, H., Evans, D. J., Farwell, W. R., Finkel, R. S., Goemans, N., de Lemus, M., Matyushenko, V., Francesco Muntoni, A., Ouillade, M.-C., Schwersenz, I., et al. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180325 · Cited by 10 · see citing works

Age- and sex-related differences in urinary excretion of 6β-hydroxycortisol in humans

Nakamura, J., & Yakata, M. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90191-3 · Cited by 9 · see citing works

Inter-individual variation in morphine clearance in children

Altamimi, M., Choonara, I., & Sammons, H. M. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1843-x · Cited by 8 · see citing works

Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials

Zhang, Q., Xu, B., Lv, J., et al. (2020) · Cardiology in the Young · doi:10.1017/s104795112000311x · Cited by 7 · see citing works

Proof of Concept: First Pediatric [14C]microtracer Study to Create Metabolite Profiles of Midazolam

van Groen, B. D., van Duijn, E., de Vries, A., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1884 · Cited by 6 · see citing works

Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift

Kearns, G. L., & van den Anker, J. N. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1862 · Cited by 4 · see citing works

Single blood pressure chart for children up to 13 years to improve the recognition of hypertension based on existing normative data

Coulthard, M. G. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-317993 · Cited by 4 · see citing works

[On a simple and reliable method for the determination of free hemoglobin in the plasma].

Kresser, M. (1967) · PubMed · Cited by 1 · see citing works

PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels

Srinivasan, A., Berkowitz, J., Friedrich, N. A., Tsang, K., Kuchi, A., Acitores, J., Zietz, M., Czarny, R. S., Liu, H., & Tatonetti, N. P. (2025) · medRxiv · doi:10.1101/2025.05.22.25328187